Package | eu.epi.february2025 |
Resource Type | CodeSystem |
Id | 300000000002 |
FHIR Version | R5 |
Source | https://simplifier.net/resolve?scope=eu.epi.february2025@1.0.0&canonical=http://ema.europa.eu/fhir/CodeSystem/300000000002 |
URL | http://ema.europa.eu/fhir/CodeSystem/300000000002 |
Version | 5.0.0 |
Status | active |
Name | EUepiannexIIcodesystem |
Title | EU EPI Annex II QRD code values |
Description | EU EPI Annex II QRD code values |
Content | complete |
No resources found
No resources found
No narrative content found in resource
{ "resourceType": "CodeSystem", "status": "active", "content": "complete", "name": "EUepiannexIIcodesystem", "id": "300000000002", "title": "EU EPI Annex II QRD code values", "description": "EU EPI Annex II QRD code values", "version": "5.0.0", "url": "http://ema.europa.eu/fhir/CodeSystem/300000000002", "concept": [ { "code": "000000000000", "display": "Code for custom sub-sections (reserved)" }, { "code": "200000029850", "display": "ANNEX II" }, { "code": "200000029851", "display": "A. <MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND> MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE" }, { "code": "200000029852", "display": "B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE" }, { "code": "200000029853", "display": "Official batch release" }, { "code": "200000029854", "display": "C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION" }, { "code": "200000029855", "display": "Periodic safety update reports (PSURs)" }, { "code": "200000029856", "display": "D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT" }, { "code": "200000029857", "display": "Risk management plan (RMP)" }, { "code": "200000029858", "display": "Additional risk minimisation measures" }, { "code": "200000029859", "display": "Obligation to conduct post-authorisation measures" }, { "code": "200000029860", "display": "E. SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR <THE CONDITIONAL MARKETING AUTHORISATION> <THE MARKETING AUTHORISATION UNDER EXCEPTIONAL CIRCUMSTANCES" } ], "experimental": false, "publisher": "European Medicines Agency", "jurisdiction": [ { "text": "European Union" } ], "caseSensitive": true, "count": 12 }